Effect of a Liquid Tonic Drink on Post-meal Glucose and Insulin Responses
No applicable phase (e.g. observational)
Conditions:
Overweight or Obese Adults
Sponsor: Australian Catholic University
trial.available_in:
БГ
Overview
A randomised, double blinded, placebo-controlled crossover design clinical trial conducted at the Mary MacKillop Institute for Health Research (MMIHR, Australian Catholic University) for individuals with overweight/ obesity. This study will measure the postprandial glucose and hormone responses to a high-carbohydrate meal with/ without a liquid tonic drink.
Description
Twenty individuals living with overweight/ obesity will be invited to attend the university laboratories on 2 separate occasions to participate in a postprandial (meal) challenge. Participants will consume the same high-carbohydrate meal on each visit, with or without a liquid tonic drink. This will be a cross-over design study, where participants will consume a placebo drink on the alternate visit. Participants will remain in the laboratory for 3-hours following the meal with a venous cannula in place, and have blood samples taken at regular timepoints. Blood samples will be analysed for glucose and appetite hormones. Participants will also wear a continuous glucose monitor throughout the period which encapsulates both study trials.
Who can participate
Inclusion Criteria:
* Aged ≥30-64 years
* Body Mass Index (BMI) of ≥27.0 kg/m2
Exclusion Criteria:
* younger than 30 or 65 years or older,
* a BMI less than 27.0 kg/m2,
* have an allergy to any of the components in the plant-based tonic (see section 6),
* pregnant or breastfeeding,
* regularly skipping breakfast (i.e. not consuming breakfast on 5/7 days per week),
* any diagnosed metabolic (e.g. diabetes), endocrine (e.g. hyperthyroidism), gastrointestinal (e.g. Crohn's) or cardiovascular (e.g. heart failure) abnormalities,
* on an energy-restricted diet; significant weight fluctuation in the previous 3 months (\>5% body weight),
* high alcohol consumption (\>14 units/week) (as per Alcohol Drink Guidelines),
* medication that is used to treat blood glucose,
* unable to attend in person testing sessions, or
* unable or unwilling to provide blood samples.